133 related articles for article (PubMed ID: 26677401)
1. MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma-a step towards personalized therapy.
Garajová I; Funel N; Fiorentino M; Agostini V; Ferracin M; Negrini M; Frassineti GL; Gavelli G; Frampton AE; Biasco G; Giovannetti E
Clin Epigenetics; 2015; 7():129. PubMed ID: 26677401
[TBL] [Abstract][Full Text] [Related]
2. Differential diagnosis of pulmonary enteric adenocarcinoma and metastatic colorectal carcinoma with the assistance of next-generation sequencing and immunohistochemistry.
Zhang J; Xiang C; Han Y; Teng H; Li X; Shao J; Zhu L; Han-Zhang H; Ye J; Yu K
J Cancer Res Clin Oncol; 2019 Jan; 145(1):269-279. PubMed ID: 30415301
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary enteric adenocarcinoma.
Gong J; Fan Y; Lu H
Transl Oncol; 2021 Aug; 14(8):101123. PubMed ID: 34000642
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary enteric adenocarcinoma: a study of the clinicopathologic and molecular status of nine cases.
Wang CX; Liu B; Wang YF; Zhang RS; Yu B; Lu ZF; Shi QL; Zhou XJ
Int J Clin Exp Pathol; 2014; 7(3):1266-74. PubMed ID: 24696747
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological, radiographic, and oncogenic features of primary pulmonary enteric adenocarcinoma in comparison with invasive adenocarcinoma in resection specimens.
Zhao L; Huang S; Liu J; Zhao J; Li Q; Wang HQ
Medicine (Baltimore); 2017 Sep; 96(39):e8153. PubMed ID: 28953659
[TBL] [Abstract][Full Text] [Related]
6. [Clinicopathological and molecular features of pulmonary enteric adenocarcinoma].
Gao G; Wang YZ; Zhang YP; Feng SE; Hou M; Xia QX
Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):544-549. PubMed ID: 32486530
[No Abstract] [Full Text] [Related]
7. Clinicopathological and genetic analyses of pulmonary enteric adenocarcinoma.
Okada F; Takeda M; Fujii T; Uchiyama T; Sasaki S; Matsuoka M; Nitta Y; Terada C; Maebo K; Morita K; Ishida E; Sawabata N; Ohbayashi C
J Clin Pathol; 2024 Jan; 77(2):111-115. PubMed ID: 36456172
[TBL] [Abstract][Full Text] [Related]
8. Combination of cadherin-17 and SATB homeobox 2 serves as potential optimal makers for the differential diagnosis of pulmonary enteric adenocarcinoma and metastatic colorectal adenocarcinoma.
Bian T; Zhao J; Feng J; Zhang Q; Qian L; Liu J; Jiang D; Liu Y; Zhang J
Oncotarget; 2017 Sep; 8(38):63442-63452. PubMed ID: 28969003
[TBL] [Abstract][Full Text] [Related]
9. Distinctive features of immunostaining and mutational load in primary pulmonary enteric adenocarcinoma: implications for differential diagnosis and immunotherapy.
Chen M; Liu P; Yan F; Xu S; Jiang Q; Pan J; He M; Shen P
J Transl Med; 2018 Mar; 16(1):81. PubMed ID: 29587865
[TBL] [Abstract][Full Text] [Related]
10. Primary Enteric Adenocarcinoma Lung with Mesenchymal Epithelial Transition Factor Amplification: A Case Report.
Shukla S; Pandey RK; Husain N; Srivastava A
Gulf J Oncolog; 2021 May; 1(36):76-78. PubMed ID: 35017140
[TBL] [Abstract][Full Text] [Related]
11. A pulmonary enteric adenocarcinoma patient harboring a rare EGFR exon 19 P753S mutation: Case report and review.
Xu X; Chen D; Wu X; Wang Q
Front Oncol; 2022; 12():988625. PubMed ID: 36212391
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics associated with ALK rearrangements in never-smokers with pulmonary adenocarcinoma.
Sun JM; Lira M; Pandya K; Choi YL; Ahn JS; Mao M; Han J; Park K; Ahn MJ; Kim J
Lung Cancer; 2014 Feb; 83(2):259-64. PubMed ID: 24300132
[TBL] [Abstract][Full Text] [Related]
13. [Progress in pulmonary enteric adenocarcinoma].
Zuo Y; Bai H; Ying JM; Wang J
Zhonghua Zhong Liu Za Zhi; 2022 Apr; 44(4):321-325. PubMed ID: 35448919
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous metastasis as a primary presentation of a pulmonary enteric adenocarcinoma.
Todisco A; Internò V; Stucci LS; Ostuni C; Lovero D; D'Oronzo S; Mele F; Duda L; Palmirotta R; Silvestris F
Int J Biol Markers; 2019 Dec; 34(4):421-426. PubMed ID: 31556336
[TBL] [Abstract][Full Text] [Related]
15. Genomic and epigenomic profiles distinguish pulmonary enteric adenocarcinoma from lung metastatic colorectal cancer.
Zuo Y; Zhong J; Bai H; Xu B; Wang Z; Li W; Chen Y; Jin S; Wang S; Wang X; Wan R; Xu J; Fei K; Han J; Yang Z; Bao H; Shao Y; Ying J; Song Q; Duan J; Wang J
EBioMedicine; 2022 Aug; 82():104165. PubMed ID: 35901658
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and treatment of primary pulmonary enteric adenocarcinoma: Report of Six cases.
Tu LF; Sheng LY; Zhou JY; Wang XF; Wang YH; Shen Q; Shen YH
World J Clin Cases; 2021 Oct; 9(30):9236-9243. PubMed ID: 34786410
[TBL] [Abstract][Full Text] [Related]
17. Identification of EGFR mutation, KRAS mutation, and ALK gene rearrangement in cytological specimens of primary and metastatic lung adenocarcinoma.
Cai G; Wong R; Chhieng D; Levy GH; Gettinger SN; Herbst RS; Puchalski JT; Homer RJ; Hui P
Cancer Cytopathol; 2013 Sep; 121(9):500-7. PubMed ID: 23495083
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological characteristics and outcomes of ROS1-rearranged patients with lung adenocarcinoma without EGFR, KRAS mutations and ALK rearrangements.
Wu S; Wang J; Zhou L; Su D; Liu Y; Liang X; Zhang S; Zeng X
Thorac Cancer; 2015 Jul; 6(4):413-20. PubMed ID: 26273395
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary Adenocarcinoma With Enteric Differentiation: Immunohistochemistry and Molecular Morphology.
Nottegar A; Tabbò F; Luchini C; Brunelli M; Bria E; Veronese N; Santo A; Cingarlini S; Gilioli E; Ogliosi C; Eccher A; Montagna L; Pedron S; Doglioni C; Cangi MG; Inghirami G; Chilosi M
Appl Immunohistochem Mol Morphol; 2018 Jul; 26(6):383-387. PubMed ID: 27753661
[TBL] [Abstract][Full Text] [Related]
20. Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement.
Kim HR; Shim HS; Chung JH; Lee YJ; Hong YK; Rha SY; Kim SH; Ha SJ; Kim SK; Chung KY; Soo R; Kim JH; Cho BC
Cancer; 2012 Feb; 118(3):729-39. PubMed ID: 21720997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]